Loading…

The wnt/β-catenin-specific inhibitor, ICG-001, proves effective for the treatment of high-grade serous ovarian cancer in murine models through the targeting of cancer initiating cells

Saved in:

Bibliographic Details
Published in:	Gynecologic oncology 2017-06, Vol.145, p.120-121
Main Authors:	Connor, R.S, Nagaraj, A.B, Joseph, P, Mantilla, S, Kovalenko, O, Nagel, C.I, Nakayama, J, Waggoner, S.E, Zanotti, K.M, Singh, S, DiFeo, A
Format:	Article
Language:	English
Subjects:	Hematology, Oncology and Palliative Medicine Obstetrics and Gynecology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!